Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-474
Closed -$231K – 1233
2025
Q2
$231K Buy
474
+44
+10% +$25.1K ﹤0.01% 1133
2025
Q1
$265K Buy
+430
New +$244K ﹤0.01% 1046
2024
Q4
– Sell
-378
Closed -$227K – 1164
2024
Q3
$227K Buy
+378
New +$214K ﹤0.01% 1075
2024
Q2
– Sell
-431
Closed -$277K – 1119
2024
Q1
$277K Buy
431
+3
+0.7% +$1.82K ﹤0.01% 960
2023
Q4
$250K Buy
+428
New +$240K ﹤0.01% 956

Other funds holding CHE

Davenport & Co's CHE Position: Q3 2025 in Review

Davenport & Co sold out of Chemed (CHE) in Q3 2025, closing a stake of 474 shares — an estimated $231K sold.

Davenport & Co first reported a position in CHE in Q4 2023 and held it in 5 quarters. The position peaked at $277K in Q1 2024. 523 funds tracked by Wall St. Rank hold CHE as of Q3 2025.

  • Davenport & Co reported no remaining Chemed position as of Q3 2025 after selling out during the quarter.
  • Davenport & Co sold 474 Chemed shares in Q3 2025, an estimated $231K.
  • Davenport & Co first reported a position in Chemed in Q4 2023 and held it in 5 quarters.
  • Davenport & Co's Chemed position peaked at $277K in Q1 2024.
  • 523 funds tracked by Wall St. Rank held Chemed as of Q3 2025.

Based on Davenport & Co's 13F filing for Q3 2025, filed 15 Oct 2025.